Clinical trials recruiting in Solothurn, Switzerland

Phase breakdown

Conditions recruiting in Solothurn, Switzerland

Recruiting trials in Solothurn, Switzerland

• Colchicine After Electrocardioversion for Atrial Fibrillation
  NCT05890664 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
  NCT05512364 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
  NCT05718323 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Pharmacist Guided Pre-emptive Pharmacogenetic Testing in Antidepressant Therapy
  NCT04507555 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer
  NCT07617610 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• The Medacta International SMS Post-Marketing Surveillance Study
  NCT02748408 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Solothurn, Switzerland?

6 recruiting trials have at least one study site in Solothurn, Switzerland.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.